Generation Bio is shedding 90% of its workforce after the biotech acknowledged that it’s unlikely to find the cash to take ...

The director of the National Institutes of Health (NIH) has said the federal government’s discontinuation of mRNA vaccine ...

More bad news has come down for Biohaven’s small molecule troriluzole. | More bad news has come down for Biohaven’s small molecule troriluzole. After the FDA decided to convene an advisory committee ...

The company said its CGM+ system can deliver accurate readings across a 15-day lifespan, while also employing fewer ...

After the Department of Health and Human Services canceled about $500 million in funding for mR | After HHS abruptly canceled ...

Activist investor Engine Capital is lobbying for big changes at Avantor, urging the life science toolmaker to either cut costs and reshape its management or sell itself outright. | The move comes as ...

Using its hub-and-spoke business model, PureTech is launching a new company to develop deupirfenidone (LYT-100), its ...

Bayer has teamed up with Kumquat Biosciences for a juicy opportunity, committing up to $1.3 billion for the global license to ...

A day after posting a pair of phase 3 wins for the tricky indication of Sjögren's syndrome, the Swiss pharma has unveiled a ...

Vaxart is actively seeking more information about why it was told to stop work under a federally funded COVID-19 vaccine ...

Another Massachusetts biotech has reached the end of the road. | Another Massachusetts biotech has reached the end of the ...

Shortly after obtaining a green light from the FDA, SetPoint Medical announced $140 million in new funding to juice the commercialization of its neuromodulation implant for rheumatoid art | Shortly ...